Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

New insights into how cells clean and recycle waste

A recent study from Tata Institute of Fundamental Research, Mumbai, India has revealed new details about how our cells clean up and recycle waste.

21 Jan 2025

CDC report reveals COPD as the sixth leading cause of death in the U.S.

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC).

21 Jan 2025

Antibiotics, antivirals, vaccines and anti-inflammatory drugs associated with reduced dementia risk

Antibiotics, antivirals, vaccinations and anti-inflammatory medication are associated with reduced risk of dementia, according to new research that looked at health data from over 130 million individuals.

21 Jan 2025

Benefits and risks of popular weight-loss drugs revealed

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity.

20 Jan 2025

New approach combines two methods to study disordered proteins

Researchers of Mainz University and EMBL Hamburg present a new approach to determine the form of disordered proteins by using two different methods simultaneously in a single sample.

20 Jan 2025

Study reveals brain aging in sickle cell patients

Individuals with sickle cell disease – a chronic illness where misshapen, sticky blood cells clump together, reducing oxygen delivery to organs – are at a higher risk for stroke and resulting cognitive disability.

17 Jan 2025

New probes offer insight into cholesterol's role in Alzheimer's disease

The search for answers to Alzheimer's disease and other neurodegenerative disorders remains one of the most pressing goals in brain research. Maciej J. Stawikowski, Ph.D., an assistant professor of chemistry and biochemistry at Florida Atlantic University's Charles E. Schmidt College of Science, believes the key may lie in understanding how cholesterol and other lipids move through cells and affect their communication.

17 Jan 2025

Early brain changes in Huntington’s disease detected two decades before symptoms

Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately twenty years before a clinical motor diagnosis in people with Huntington's disease, finds a new study led by UCL researchers.

17 Jan 2025

Air pollution amplifies dementia risk in cardiometabolic disease patients - healthy habits can help

CMD patients face a 2x higher risk of dementia and MCI, but healthier lifestyles can counter air pollution's impact and reduce these risks.

16 Jan 2025

Xenon gas offers potential neuroprotective effects for Alzheimer's patients

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research from Mass General Brigham and Washington University School of Medicine in St. Louis points to a novel-and noble-approach: using Xenon gas.

16 Jan 2025

Eating greater quantities of red meat may increase risk of dementia

Red meat consumption is an established risk factor for chronic conditions, including cardiovascular disease and type 2 diabetes.

15 Jan 2025

Spear Bio secures FDA breakthrough device designation for its novel pTau 217 blood test, advancing scalable solutions for early Alzheimer's disease diagnosis

Spear Bio Inc., a biotechnology company pioneering next-generation ultra-sensitive immunoassays, today announced that its pTau 217 blood test has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

From Spear Bio 15 Jan 2025

Alzheimer's Disease News and Research

Further Reading

New insights into how cells clean and recycle waste

CDC report reveals COPD as the sixth leading cause of death in the U.S.

Antibiotics, antivirals, vaccines and anti-inflammatory drugs associated with reduced dementia risk

Benefits and risks of popular weight-loss drugs revealed

New approach combines two methods to study disordered proteins

Study reveals brain aging in sickle cell patients

New probes offer insight into cholesterol's role in Alzheimer's disease

Early brain changes in Huntington’s disease detected two decades before symptoms

Air pollution amplifies dementia risk in cardiometabolic disease patients - healthy habits can help

Xenon gas offers potential neuroprotective effects for Alzheimer's patients

Eating greater quantities of red meat may increase risk of dementia

Spear Bio secures FDA breakthrough device designation for its novel pTau 217 blood test, advancing scalable solutions for early Alzheimer's disease diagnosis

Study uncovers mechanism for cognitive improvement in dementia

Blood vessel dysfunction in brain's temporal lobes linked to mild cognitive impairment

U.S. dementia cases expected to surge with aging population

CeVD-related brain network phenotype can provide insights into cognitive decline trajectory

Early diagnosis of Dementia with Lewy Bodies could be improved by cognitive profiling

Sex-specific mitochondrial marker deficiencies linked to early cognitive dysfunction in Alzheimer’s disease

Could autophagy enhancement slow aging and combat Alzheimer's?

Could camembert cheese hold the key to better memory?

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News